Genetic Testing Market
Genetic Testing Market - Global Industry Assessment & Forecast
#
Pages:
214
Base Year:
2024
Oct - 2024
Format:
Report Code:
VMR-3019
Segments Covered
By
Test Type Diagnostic Testing, Predictive and Presymptomatic Testing, Carrier Testing, Prenatal and Newborn Screening, Pharmacogenomic Testing, Other
-
By
Technology Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Chromosomal Microarray, Fluorescence In Situ Hybridization (FISH), Sanger Sequencing
-
By
Application Oncology, Rare Diseases, Neurological Disorders, Cardiovascular Diseases, Genetic Disease Risk Assessment, Ancestry Testing, Paternity Testing, Other
-
By
End-User Hospitals and Clinics, Diagnostic Laboratories, Research Institutes, Direct-to-Consumer (DTC) Testing Services, Forensic Laboratories, Other
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2024 |
| Forecast
Years:
|
2025 - 2034 |
 Historical
Years:
|
2019 - 2023 |
 Revenue
2024: |
USD 22.60 Billion |
 Revenue 2034:
|
USD 65.91 Billion |
 Revenue CAGR
(2025 - 2034): |
11.3% |
Fastest Growing Region (2025 -
2034)
|
Asia Pacific |
Largest Region (2024):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Genetic Testing Market Segment Analysis
- Genetic Testing Test Type Outlook (Revenue, USD Million, 2018 - 2030)
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- Genetic Testing Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- Genetic Testing Application Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- Genetic Testing End-User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
-
North America Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
-
North America Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
-
North America Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- U.S.
- U.S. Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- U.S. Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- U.S. Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- U.S. Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- U.S. Genetic Testing Market, by Test Type
- Canada
- Canada Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- Canada Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- Canada Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- Canada Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- Canada Genetic Testing Market, by Test Type
-
Mexico
- Mexico Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- Mexico Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- Mexico Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- Mexico Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- Mexico Genetic Testing Market, by Test Type
-
North America Genetic Testing Market, by Test Type
- Europe
-
Europe Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
-
Europe Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
-
Europe Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
-
Europe Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- U. K.
- U.K. Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- U.K. Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- U.K. Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- U.K. Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- U.K. Genetic Testing Market, by Test Type
- France
- France Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- France Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- France Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- France Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- France Genetic Testing Market, by Test Type
-
Germany
- Germany Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- Germany Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- Germany Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- Germany Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- Germany Genetic Testing Market, by Test Type
-
Italy
- Italy Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- Italy Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- Italy Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- Italy Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- Italy Genetic Testing Market, by Test Type
-
Spain
- Spain Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- Spain Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- Spain Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- Spain Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- Spain Genetic Testing Market, by Test Type
-
Rest of Europe
- Rest of Europe Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- Rest of Europe Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- Rest of Europe Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- Rest of Europe Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- Rest of Europe Genetic Testing Market, by Test Type
-
Europe Genetic Testing Market, by Test Type
- Asia Pacific
-
Asia Pacific Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
-
Asia Pacific Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
-
Asia Pacific Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
-
Asia Pacific Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- China
- China Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- China Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- China Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- China Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- China Genetic Testing Market, by Test Type
- Japan
- Japan Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- Japan Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- Japan Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- Japan Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- Japan Genetic Testing Market, by Test Type
-
Germany
- Germany Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- Germany Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- Germany Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- Germany Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- Germany Genetic Testing Market, by Test Type
-
India
- India Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- India Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- India Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- India Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- India Genetic Testing Market, by Test Type
-
South Korea
- South Korea Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- South Korea Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- South Korea Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- South Korea Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- South Korea Genetic Testing Market, by Test Type
-
South East Asia
- South East Asia Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- South East Asia Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- South East Asia Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- South East Asia Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- South East Asia Genetic Testing Market, by Test Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- Rest of Asia Pacific Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- Rest of Asia Pacific Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- Rest of Asia Pacific Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- Rest of Asia Pacific Genetic Testing Market, by Test Type
-
Asia Pacific Genetic Testing Market, by Test Type
- Latin America
-
Latin America Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
-
Latin America Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
-
Latin America Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
-
Latin America Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- Brazil
- Brazil Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- Brazil Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- Brazil Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- Brazil Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- Brazil Genetic Testing Market, by Test Type
- Argentina
- Argentina Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- Argentina Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- Argentina Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- Argentina Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- Argentina Genetic Testing Market, by Test Type
-
Rest of Latin America
- Rest of Latin America Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- Rest of Latin America Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- Rest of Latin America Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- Rest of Latin America Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- Rest of Latin America Genetic Testing Market, by Test Type
-
Latin America Genetic Testing Market, by Test Type
- Middle East & Africa
-
Middle East & Africa Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
-
Middle East & Africa Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
-
Middle East & Africa Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
-
Middle East & Africa Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- GCC Countries
- GCC Countries Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- GCC Countries Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- GCC Countries Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- GCC Countries Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- GCC Countries Genetic Testing Market, by Test Type
- South Africa
- South Africa Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- South Africa Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- South Africa Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- South Africa Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- South Africa Genetic Testing Market, by Test Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Genetic Testing Market, by Test Type
- Diagnostic Testing
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Screening
- Pharmacogenomic Testing
- Other
- Rest of Middle East & Africa Genetic Testing Market, by Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Chromosomal Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- Rest of Middle East & Africa Genetic Testing Market, by Application
- Oncology
- Rare Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Genetic Disease Risk Assessment
- Ancestry Testing
- Paternity Testing
- Other
- Rest of Middle East & Africa Genetic Testing Market, by End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Direct-to-Consumer (DTC) Testing Services
- Forensic Laboratories
- Other
- Rest of Middle East & Africa Genetic Testing Market, by Test Type
-
Middle East & Africa Genetic Testing Market, by Test Type
- North America
Vantage Market
Research | 06-Nov-2024
FAQ
Frequently Asked Question
What is the global demand for Genetic Testing in terms of revenue?
-
The global Genetic Testing valued at USD 22.60 Billion in 2024 and is expected to reach USD 65.91 Billion in 2034 growing at a CAGR of 11.3%.
Which are the prominent players in the market?
-
The prominent players in the market are Abbott Laboratories, Danaher Corporation (Cepheid Inc.), Illumina Inc., BioRad Laboratories Inc., F. Hoffmann-La Roche Ltd, 23andMe Inc., Myriad Genetics Inc., DiaSorin S.p.A. (Luminex Corporation), PerkinElmer Inc., Quest Diagnostics Incorporated, Eurofins Scientific, Qiagen N.V., Thermo Fisher Scientific, Invitae Corporation, Agilent Technologies..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 11.3% between 2025 and 2034.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Genetic Testing include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Genetic Testing in 2024.
